About this trial
The goal of this observational study is to learn about the factors which determine how well ventricular tachycardia (VT) is tolerated. The main questions it aims to answer are:
1. What impact does coronary artery disease have on the ability for a patient to tolerate VT? 2. Does treatment of coronary artery disease with stents improve the tolerability of VT?
Participants who are undergoing a clinically indicated coronary angiogram or coronary angioplasty procedure will have measurements of blood pressure, coronary pressure and coronary flow made during pacing at a range of heart rates.
Eligibility criteria
Qualifiers
Able to give valid consent
Referred for coronary angiography or coronary angioplasty
Suitable for percutaneous physiological interrogation and PCI when clinically indicated
Disqualifiers
Unable to give valid consent
Pregnant or breastfeeding women
Unstable coronary artery disease (acute coronary syndrome)
Severe multivessel coronary artery disease suitable for coronary artery bypass grafting
Trial design
Treatments tested in this trial
- Pressure and flow measurement during simulated VT